TNF, tumour necrosis factor

Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems
J Braun, X Baraliakos, W Golder, K-G Hermann, J Listing, J Brandt, M Rudwaleit, S Zuehlsdorf, M Bollow, J Sieper, D van der Heijde

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1046-1055; DOI: 10.1136/ard.2003.019968
Blockade of tumour necrosis factor α significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis
B Yazdani-Biuki, E Stadlmaier, A Mulabecirovic, R Brezinschek, G Tilz, U Demel, T Mueller, K Brickmann, W B Graninger, H-P Brezinschek

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1224-1226; DOI: 10.1136/ard.2004.030262
Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines
Wolfgang Hueber, Beren H Tomooka, Xiaoyan Zhao, Brian A Kidd, Jan W Drijfhout, James F Fries, Walther J van Venrooij, Allan L Metzger, Mark C Genovese, William H Robinson

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 712-719; DOI: 10.1136/ard.2006.054924
Rheumatoid arthritis and genetic markers in Syrian and French populations: different effect of the shared epitope
Leyla Kazkaz, Hubert Marotte, Mayassa Hamwi, Marie Angélique Cazalis, Pascal Roy, Bruno Mougin, Pierre Miossec

Annals of the Rheumatic Diseases Feb 2007, 66 (2) 195-201; DOI: 10.1136/ard.2004.033829
Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
M H Schiff, G R Burmester, J D Kent, A L Pangan, H Kupper, S B Fitzpatrick, C Donovan

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 889-894; DOI: 10.1136/ard.2005.043166
A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment
P Durez, A Nzeusseu Toukap, B R Lauwerys, D H Manicourt, P Verschueren, R Westhovens, J-P Devogelaer, F A Houssiau

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1069-1074; DOI: 10.1136/ard.2003.012914
Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis
A Finckh, J F Simard, C Gabay, P-A Guerne

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 746-752; DOI: 10.1136/ard.2005.045062
Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study
P L C M van Riel, A J Taggart, J Sany, M Gaubitz, H W Nab, R Pedersen, B Freundlich, D MacPeek

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1478-1483; DOI: 10.1136/ard.2005.043299
Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis
M C Kraan, T J M Smeets, M J van Loon, F C Breedveld, B A C Dijkmans, P P Tak

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1056-1061; DOI: 10.1136/ard.2003.014738
Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses
Elena Gonzalez-Rey, Alejo Chorny, Raimundo G Del Moral, Nieves Varela, Mario Delgado

Annals of the Rheumatic Diseases May 2007, 66 (5) 582-588; DOI: 10.1136/ard.2006.062703

Main menu

TNF, tumour necrosis factor

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

TNF, tumour necrosis factor

Pages